CWM
IDXX icon

Cranbrook Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Cranbrook Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343K Hold
611
– – 0.07% 100
2025
Q4 		$413K Buy
611
+240
+65% +$163K 0.08% 92
2025
Q3 		$237K Hold
371
– – 0.05% 120
2025
Q2 		$199K Hold
371
– – 0.04% 118
2025
Q1 		$156K Sell
371
-11
-3% -$4.78K 0.04% 123
2024
Q4 		$158K Buy
382
+25
+7% +$11K 0.04% 123
2024
Q3 		$180K Hold
357
– – 0.04% 116
2024
Q2 		$174K Buy
+357
New +$179K 0.04% 114

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cranbrook Wealth Management's IDXX Position: Q1 2026 in Review

Cranbrook Wealth Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 611 shares worth $343K. The position accounts for 0.07% of the portfolio, ranked #100.

Cranbrook Wealth Management first reported a position in IDXX in Q2 2024 and has held it in 8 quarters since. The position peaked at $413K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Cranbrook Wealth Management held 611 shares of Idexx Laboratories worth $343K as of Q1 2026.
  • Cranbrook Wealth Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.07% of Cranbrook Wealth Management's portfolio in Q1 2026, its #100 holding.
  • Cranbrook Wealth Management first reported a position in Idexx Laboratories in Q2 2024 and has held it in 8 quarters since.
  • Cranbrook Wealth Management's Idexx Laboratories position peaked at $413K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.